Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10906916
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10898475
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted -
US 10899738
Piperidines as menin inhibitors
granted -
US 10894786
Substituted pyrazole derivatives as selective CDK12/13 inhibitors
granted -
US 10894044
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
granted -
US 10894797
Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
granted -
US 10894052
Heterocyclic inhibitors of ATR kinase
granted -
US 10888609
CD200 inhibitors and methods of use thereof
granted -
US 10889592
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
granted -
US 10881666
Combination pharmaceutical agents as RSV inhibitors
granted -
US 10881669
Inhibitors of the plasmodial surface anion channel as antimalarials
granted -
US 10881646
Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers
granted -
US 10874673
Inhibitors of influenza viruses replication
granted -
US 10874649
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
granted -
US 10874648
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10875855
Inhibitors of influenza viruses replication
granted -
US 10874631
Altertoxin II as a selective inhibitor of Ewing family of tumor cells
granted -
US 10869865
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted -
US 10870645
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
granted -
US 10870854
Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment
granted -
US 10865215
Benzodiazepine derivatives as RSV inhibitors
granted -
US 10864217
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
granted -
US 10864222
Beta-lactamase inhibitors, formulations, and uses thereof
granted -
US 10858338
Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH)
granted